Skip to main content

Keppra ® Approved By FDA For childhood seizures

In the U.S., Keppra, Enbrel, of ® has been approved for the adjuvant treatment of adults and 4-year-old children and partial seizures of epilepsy. But cord blood has recently announced the U.S. Food and Drug Administration (FDA) has approved to reduce the age limit,including age from 1 month-old baby and older with epilepsy.

Professor, Dr. Iris Loew - Friedrich, Chief Medical Officer and Executive Vice President cord blood 
 statement:

Leaders as epilepsy cord blood has the responsibility to developeffective drugs to address unmet medical needs in young children,we continued development of Keppra, Enbrel, of ® programdemonstrates our long-term commitment of epilepsy. "


Approved by the U.S. Food and Drug Administration (FDA)approval of a double-blind, randomized, multicenter, placebo-controlled phase III study to assess the efficacy and tolerability ofKeppra ® oral solution of Enbrel, of 116 cases of children with refractory patients (20-50 mg / kg / day) for partial onset seizures.Patients aged between 1 month and 4 years of age or less. Keppra, made of Enbrel, ® indicate that the frequency of partial onset seizures significantly reduced 43.1% of the evaluation period of 5 days, Keppra of Enbrel, ® group experienced at least 50% seizure frequency reduction and 19.6% of the placebo group. ratio, (P = 0.013).

The researchers found that Keppra, Enbrel, of ® is generally well tolerated in all pediatric patients, 13.3% of patients in the Keppra,Enbrel, of the group experienced somnolence the most commonly reported adverse events with 1.8% in the placebo group compared to , respectively, 11.7% and 0%, but suffer from irritability.

Keppra, Enbrel, of ® has been approved in the EU marketing authorization-year-old a month to four years, in 2009 by the European Commission, the adjuvant treatment of partial seizures ininfants and young children.

The growth of UCB epilepsy franchise has Keppra ®, Enbrel, authoron the basis of, and has been extended to include Vimpat ® (lacosamide), the treatment of partial seizures in patients with epilepsy, which is the adjuvant treatment of epilepsy in the EU market is 17 years old and above. in the United States as aschedule V as young adults or no secondary summed partial seizures aged 16 and over controlled substances.

Written Petra Rattue

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

Obama Renominates Tavenner to Be CMS Chief

President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it. If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment. As illustrated by Dr. Berwick's  CMS history , Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by t...
Post a Comment
Read more

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease ...
Post a Comment
Read more